Christa Wirthumer-Hoche, head of the Austrian Medicines and Medical Devices Agency (AGES) and chair of the European Medicines Agency (EMA) management board, discusses the role of AGES within Austria, similarities with other countries’ regulatory agencies, Austria’s potential as an innovation hub, and the possible relocation of the EMA to Vienna in the wake of Brexit.
AGES and BASG (Austrian Federal Office for Safety in Health) are often compared to the US FDA, what are the similarities and the differences?
"Austria is a rather small country with a mid-sized agency in terms of staff members, but we are a very active partner in all the scientific work in the European network."
